Amgen Inc.AMGNNASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q4 2025 | 13.21% |
| Q3 2025 | 8.94% |
| Q2 2025 | 17.36% |
| Q1 2025 | -13.81% |
| Q4 2024 | 18.90% |
| Q3 2024 | 0.21% |
| Q2 2024 | 7.74% |
| Q1 2024 | -12.45% |
| Q4 2023 | 42.17% |
| Q3 2023 | -3.05% |
| Q2 2023 | 5.20% |
| Q1 2023 | -20.09% |
| Q4 2022 | 19.06% |
| Q3 2022 | 7.03% |
| Q2 2022 | 8.34% |
| Q1 2022 | -28.86% |
| Q4 2021 | -5.20% |
| Q3 2021 | 31.42% |
| Q2 2021 | 11.89% |
| Q1 2021 | -21.32% |
| Q4 2020 | 15.73% |
| Q3 2020 | 10.17% |
| Q2 2020 | 1.26% |
| Q1 2020 | -27.44% |
| Q4 2019 | 31.07% |
| Q3 2019 | 8.33% |
| Q2 2019 | 5.12% |
| Q1 2019 | -25.63% |
| Q4 2018 | 27.65% |
| Q3 2018 | 6.56% |
| Q2 2018 | 14.34% |
| Q1 2018 | -27.13% |
| Q4 2017 | 18.93% |
| Q3 2017 | 0.46% |
| Q2 2017 | 13.52% |
| Q1 2017 | -28.66% |
| Q4 2016 | 8.89% |
| Q3 2016 | 10.00% |
| Q2 2016 | 3.21% |
| Q1 2016 | -20.22% |